Skip to main content
. 2023 Jun 16;325(1):H187–H194. doi: 10.1152/ajpheart.00270.2023

Figure 2.

Figure 2.

Spearman correlation between improvements in nitric oxide (NO)-mediated endothelium-dependent dilation in vivo, as assessed by brachial artery flow-mediated dilation, and acetylcholine (ACh)-stimulated NO production ex vivo with chronic mitochondria-targeted antioxidant (MitoQ) treatment [difference in percent change (%change) between placebo and MitoQ] (n = 19).